Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibudilast for Alcohol Dependence
NCT02025998Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in alcohol use disorder (AUD) comparing Ibudilast Sequence with Placebo Sequence (2 arms). Primary endpoint: Subjective response to alcohol at 4 hours. Started Dec 2013; status: completed.
02
Drugs
ibudilast
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02025998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025998.